Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Assets (2016 - 2025)

Cellectis has reported Assets over the past 12 years, most recently at $324.7 million for Q4 2025.

  • Quarterly results put Assets at $324.7 million for Q4 2025, down 15.34% from a year ago — trailing twelve months through Dec 2025 was $324.7 million (down 15.34% YoY), and the annual figure for FY2025 was $324.7 million, down 15.34%.
  • Assets for Q4 2025 was $324.7 million at Cellectis, down from $383.5 million in the prior quarter.
  • Over the last five years, Assets for CLLS hit a ceiling of $383.5 million in Q4 2024 and a floor of $209.7 million in Q3 2023.
  • Median Assets over the past 5 years was $324.7 million (2025), compared with a mean of $303.3 million.
  • Biggest five-year swings in Assets: plummeted 31.63% in 2022 and later grew 27.97% in 2023.
  • Cellectis' Assets stood at $382.1 million in 2021, then tumbled by 31.63% to $261.2 million in 2022, then rose by 27.97% to $334.3 million in 2023, then rose by 14.74% to $383.5 million in 2024, then decreased by 15.34% to $324.7 million in 2025.
  • The last three reported values for Assets were $324.7 million (Q4 2025), $383.5 million (Q4 2024), and $334.3 million (Q4 2023) per Business Quant data.